Past congresses

The Extracellular Matrix Pharmacology Congress is a biannual event that brings together leading experts across borders and generations to discuss how to modulate the ECM in different disease areas. The central theme of every ECM congress revolves around target discovery and drug development, intending to cross-fertilize and assist drug development.

Dysregulation of the ECM, characterized by either elevated degradation or formation of tissues, is a universal characteristic observed in many chronic diseases. To make a real impact on the lives of patients, we need to learn from other diseases where fibrosis and tissue destruction are central mechanisms involved in the pathophysiology.

So far, we’ve matched the success of the first congress in 2022 with the second iteration in 2024, attracting even more on-site visitors (450 participants), achieving a broader global reach (30 countries), and receiving more abstracts (230 submissions).

Get a glimpse of the previous congresses here:

• ECM2022
• ECM2024

We hope to meet you at ECM2026!